BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17913817)

  • 1. Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine.
    Ljungberg K; Whitmore AC; Fluet ME; Moran TP; Shabman RS; Collier ML; Kraus AA; Thompson JM; Montefiori DC; Beard C; Johnston RE
    J Virol; 2007 Dec; 81(24):13412-23. PubMed ID: 17913817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine.
    Fluet ME; Whitmore AC; Moshkoff DA; Fu K; Tang Y; Collier ML; West A; Moore DT; Swanstrom R; Johnston RE; Davis NL
    Virology; 2008 Jan; 370(1):22-32. PubMed ID: 17904185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.
    Pushko P; Bray M; Ludwig GV; Parker M; Schmaljohn A; Sanchez A; Jahrling PB; Smith JF
    Vaccine; 2000 Aug; 19(1):142-53. PubMed ID: 10924796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice.
    White LJ; Parsons MM; Whitmore AC; Williams BM; de Silva A; Johnston RE
    J Virol; 2007 Oct; 81(19):10329-39. PubMed ID: 17652394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.
    Agnihothram S; Menachery VD; Yount BL; Lindesmith LC; Scobey T; Whitmore A; Schäfer A; Heise MT; Baric RS
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles.
    Balasuriya UB; Heidner HW; Hedges JF; Williams JC; Davis NL; Johnston RE; MacLachlan NJ
    J Virol; 2000 Nov; 74(22):10623-30. PubMed ID: 11044106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
    Perri S; Greer CE; Thudium K; Doe B; Legg H; Liu H; Romero RE; Tang Z; Bin Q; Dubensky TW; Vajdy M; Otten GR; Polo JM
    J Virol; 2003 Oct; 77(19):10394-403. PubMed ID: 12970424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system.
    Dong M; Zhang PF; Grieder F; Lee J; Krishnamurthy G; VanCott T; Broder C; Polonis VR; Yu XF; Shao Y; Faix D; Valente P; Quinnan GV
    J Virol; 2003 Mar; 77(5):3119-30. PubMed ID: 12584337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector.
    Caley IJ; Betts MR; Irlbeck DM; Davis NL; Swanstrom R; Frelinger JA; Johnston RE
    J Virol; 1997 Apr; 71(4):3031-8. PubMed ID: 9060663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques.
    Chen L; Ewing D; Subramanian H; Block K; Rayner J; Alterson KD; Sedegah M; Hayes C; Porter K; Raviprakash K
    J Virol; 2007 Nov; 81(21):11634-9. PubMed ID: 17715224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.
    Harrington PR; Yount B; Johnston RE; Davis N; Moe C; Baric RS
    J Virol; 2002 Jan; 76(2):730-42. PubMed ID: 11752163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles.
    Cecil C; West A; Collier M; Jurgens C; Madden V; Whitmore A; Johnston R; Moore DT; Swanstrom R; Davis NL
    Virology; 2007 Jun; 362(2):362-73. PubMed ID: 17275057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease.
    Gipson CL; Davis NL; Johnston RE; de Silva AM
    Vaccine; 2003 Sep; 21(25-26):3875-84. PubMed ID: 12922122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Venezuelan equine encephalitis replicon particles packaged in different coats.
    Kamrud KI; Alterson KD; Andrews C; Copp LO; Lewis WC; Hubby B; Patel D; Rayner JO; Talarico T; Smith JF
    PLoS One; 2008 Jul; 3(7):e2709. PubMed ID: 18628938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of immune responses to gonococcal PorB delivered as outer membrane vesicles, recombinant protein, or Venezuelan equine encephalitis virus replicon particles.
    Zhu W; Thomas CE; Chen CJ; Van Dam CN; Johnston RE; Davis NL; Sparling PF
    Infect Immun; 2005 Nov; 73(11):7558-68. PubMed ID: 16239559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA.
    Velders MP; McElhiney S; Cassetti MC; Eiben GL; Higgins T; Kovacs GR; Elmishad AG; Kast WM; Smith LR
    Cancer Res; 2001 Nov; 61(21):7861-7. PubMed ID: 11691804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy.
    Caley IJ; Betts MR; Davis NL; Swanstrom R; Frelinger JA; Johnston RE
    Vaccine; 1999 Aug; 17(23-24):3124-35. PubMed ID: 10462249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
    Tretyakova I; Tibbens A; Jokinen JD; Johnson DM; Lukashevich IS; Pushko P
    Vaccine; 2019 May; 37(25):3317-3325. PubMed ID: 31072736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
    Sheahan T; Whitmore A; Long K; Ferris M; Rockx B; Funkhouser W; Donaldson E; Gralinski L; Collier M; Heise M; Davis N; Johnston R; Baric RS
    J Virol; 2011 Jan; 85(1):217-30. PubMed ID: 20980507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.